Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Vasc Med. 2009 May;14(2):129–136. doi: 10.1177/1358863X08098273

Table 3.

Correlation of total bilirubin levels (T. Bili) to various relevant parameters in all individuals (including controls), individuals with type 1 diabetes (T1 DM), and individuals with type 2 diabetes (T2 DM)

All individuals T1 DM T2 DM
T. Bili T. Bili T. Bili
% change FMD -0.125 (0.032) -0.052 (0.763) -0.053 (0.450)
% change NID -0.060 (0.333) -0.157 (0.390) -0.088 (0.234)
% change Ach -0.157 (0.019) -0.128 (0.465) -0.214 (0.008)
% change SNp -0.100 (0.137) -0.060 (0.731) -0.103 (0.206)
Age -0.004 (0.959) -0.100 (0.556) 0.012 (0.857)
BMI -0.126 (0.027) 0.061 (0.720) -0.239 (0.000)
Hemoglobin 0.189 (0.001) 0.450 (0.005) 0.163 (0.017)
Hematocrit 0.434 (0.000) 0.447 (0.006) 0.427 (0.000)
RBC 0.401 (0.000) 0.505 (0.001) 0.384 (0.000)

Data are r (p).

FMD, flow-mediated dilation; NID, nitroglycerin-induced dilation; Ach, acetylcholine; SNp, sodium nitroprusside; BMI, body mass index; RBC, red blood cell.

HHS Vulnerability Disclosure